GlassScriptPhysician profile
Ginger N Cathey
NPI 1093768145
$2,698.43
in general payments reported to CMS, 2019-2025
21 companies · $249 in 2025
The $249 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $442 · 2020: $334 · 2021: $385 · 2022: $348 · 2023: $586 · 2024: $354 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,188.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $622.59 | 2019-2024 | Solyx Sis System, Advantage System |
| Sumitomo Pharma America, INC. | $362.59 | 2023-2025 | Gemtesa |
| Astellas Pharma US INC | $313.33 | 2019-2023 | Myrbetriq |
| Abbvie INC. | $296.59 | 2020-2025 | Botox |
| Allergan, INC. | $211.47 | 2019-2022 | |
| Coloplast Corp | $189.20 | 2019-2025 | Saffron |
| Axonics, INC. | $131.88 | 2022-2024 | Axonics |
| 180 Medical, INC. | $111.95 | 2019-2024 | |
| Laborie Medical Technologies Corp. | $72.11 | 2020-2023 | |
| Pfizer INC. | $71.77 | 2019-2022 | |
| Coopersurgical, INC. | $64.04 | 2019 | |
| Ascend Therapeutics US, LLC | $47.57 | 2020-2021 | |
| Medtronic, INC. | $42.80 | 2021 | |
| Millicent US INC | $36.96 | 2023-2024 | Femring, Intrarosa |
| Caldera Medical, INC | $26.41 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $20.12 | 2022 | |
| Myovant Sciences INC. | $19.95 | 2021 | |
| Convatec INC. | $16.81 | 2019 | |
| Duchesnay USA Incorporated | $16.45 | 2019 | |
| Therapeuticsmd, INC. | $13.50 | 2019 | |
| Ambu INC. | $10.34 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ginger Cathey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.